NCT04917809 2026-04-22A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder CancerMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting20 enrolled
NCT04172675 2026-02-24A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)Janssen Research & Development, LLCPhase 2 Completed107 enrolled 17 charts